Science
Anti-fibrotic drug could be repurposed to control cell communication
Publication: Phys.org - latest science and technology news stories
Author: Not available in collected metadata
Source published: 30/09/2026, 21:20:13 UTC
Briefing created: 30/09/2026, 23:37:40 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 30/09/2026, 21:25:24 UTC.
Briefings
A University of Surrey study identified that the experimental antifibrotic drug SD-208 significantly decreases the release of extracellular vesicles, which are microscopic packages carrying biological signals between cells. This mechanism may help control cell communication, offering potential therapeutic applications for conditions involving excessive scar tissue formation.
Key points
- The drug SD-208, an experimental antifibrotic compound, substantially reduced the release of extracellular vesicles compared to controls.
- Extracellular vesicles are microscopic packages used by cells to carry proteins and other biological signals to neighboring and distant cells.
Context and limitations
The study was conducted in an experimental setting and does not yet confirm the drug's safety or efficacy in human patients.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 30/09/2026, 23:37:40 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeig7mvkwlthyhbg2vaxhruouexwz2po2t22lmdfo222sntxfzfgfv4